Table 2: AF Burden: Summary of Published Results.
| Larson et al. 2020[48] | Makati et al. 2020[49] | Gersak et al. 2016[50] | |
|---|---|---|---|
| Patients with continuous monitoring (n) | 92 | 84 | 76 |
| Persistent/long-standing persistent AF | 88% | 100% | 95% |
| Follow-up time | 12 months | 12–24 months | 12 months, 24 months |
| Residual AF burden | Mean 2.8% | Mean 8.5% | Median 0.1% (12 months), 0.4% (24 months) |
| ≤10% AF burden | 82% (12 months), 73% (24 months) | ||
| ≤5% AF burden | 94% | 88% | |
| ≤3% AF burden | 75% (12 months), 70% (24 months) | ||
| ≤1% AF burden | 80% | 69% (12 months), 66% (24 months) | |
| ≤0.5% AF burden | 62% (12 months), 62% (24 months) |